Published in Cardiovascular Device Liability Week, October 21st, 2007
Researchers studied patterns of implantable cardioverter defibrillator (ICD) use for a two-year period among 13,034 patients hospitalized with heart failure in 217 hospitals participating in the American Heart Association's Get With The Guidelines - Heart Failure quality improvement program. They found that among those eligible for ICD therapy, only 35 percent actually had one of the devices in place or had plans for the therapy when they left the hospital.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.